RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Valdecoxib produces significantly fewer hospitalizations and is cost neutral compared with diclofenac for patients with rheumatoid arthritis in the UK healthcare setting

Von Scheele, B. (2004). Valdecoxib produces significantly fewer hospitalizations and is cost neutral compared with diclofenac for patients with rheumatoid arthritis in the UK healthcare setting. Annals of the Rheumatic Diseases, 63, 518-518.

Publications Info

To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.